While working on a postgraduate research project on ‘Pharmacovigilance in Africa’ through a grant from The University of Ferrara Italy and utilizing resources available at Queens University in New York, our founder Eric became increasingly aware that besides the safety concern of the drugs marketed in Africa, access and cost were major issues to address.

The average life expectancy is 63 years mainly due to infant mortality and lack of management of chronic diseases like hypertension, diabetes and many others. One frequent trips to Africa during the project, he realized that most drugs commonly used to manage these chronic conditions were either unavailable, substandard or very pricy due to inefficiency in supply chain, lack of inventory management or unscrupulous middle men price hikes.